SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-067634
Filing Date
2019-11-26
Accepted
2019-11-26 16:30:40
Documents
12
Period of Report
2019-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1923943-1_8k.htm   iXBRL 8-K 23020
  Complete submission text file 0001104659-19-067634.txt   196972

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adap-20191123.xsd EX-101.SCH 3195
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20191123_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20191123_pre.xml EX-101.PRE 22716
13 EXTRACTED XBRL INSTANCE DOCUMENT tm1923943-1_8k_htm.xml XML 3671
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 191251435
SIC: 2836 Biological Products, (No Diagnostic Substances)